Pharmacy Times

JUNE 1, 2025

MRD testing transforms multiple myeloma treatment, guiding personalized strategies and improving patient outcomes through innovative testing methods.

100

100

Pharmaceutical Commerce

JUNE 1, 2025

At Advanced Therapies Week 2025, Rohin Iyer, Senior Director of Global CGT Operations at Marken, sat down for an exclusive interview with Phacilitate, offering perspective on the transformative advancements, emerging challenges, and future directions shaping the advanced therapies landscape. In this compelling discussion, Rohin explores key trends, including the increasing approval rates of allogeneic and autologous therapies, the exponential growth in the cell and gene therapy sector, and the s

52

52

Pharmacy Times

JUNE 1, 2025

Experts discuss BiTE therapy in treating lung cancers, focusing on innovative agents like tarlatamab and amivantimab, and their toxicity management.

73

73

pharmaphorum

JUNE 1, 2025

Regeneron's PD-1 inhibitor Libtayo hits the mark where MSD's Keytruda missed in a form of non-melanoma skin cancer

68

68

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Commerce

JUNE 1, 2025

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Markens patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies.

Patient Care 52

Patient Care 52

Pharmacy Times

JUNE 1, 2025

Brge G. Nordestgaard, MD, DMSc, discussed the role of remnant cholesterol as an independent risk factor for atherosclerotic cardiovascular disease and the emerging therapies that may help manage residual cardiovascular risk beyond low-density lipoprotein cholesterol reduction.

65

65

Pharmacy Times

JUNE 1, 2025

Incretin-based therapies, including GLP-1 and dual GLP-1/GIP receptor agonists, are transforming the management of type 2 diabetes, obesity, and cardiovascular risk.

65

65

pharmaphorum

JUNE 1, 2025

Discover Johnson & Johnsons groundbreaking Breathtaking campaign, unveiled at ASCO 2025 in Chicago. Watch the exclusive interview with Biljana Naumovic for insights into J&Js patient-first approach and the Oncology Care Index.

78

78

Pharmacy Times

JUNE 1, 2025

Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns.

65

65

Pharmaceutical Commerce

JUNE 1, 2025

Radiopharmaceuticals are transforming cancer treatment, but their short half-lives and radioactive properties demand flawless, time-critical logistics. Markens integrated one UPS network ensures secure, temperature-controlled and compliant delivery every time - accelerating access to these life-saving therapies.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JUNE 1, 2025

Stanford Health Care is stepping up its partnership with startup Atropos Health to integrate real-world evidence into physicians' workflow and clinical notes.

48

48

Pharmaceutical Commerce

JUNE 1, 2025

When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.

Communication 52

Communication 52

PharmTech

JUNE 1, 2025

Webinar Date/Time: Thu, Jun 26, 2025 11:00 AM EDT

52

52

pharmaphorum

JUNE 1, 2025

Pfizer's BRAF inhibitor Braftovi achieved a 51% reduction in the risk of death in the BREAKWATER trial, setting up full FDA approval

FDA 55

FDA 55

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmTech

JUNE 1, 2025

This new case study demonstrates how a non-destructive container closure integrity test method can be developed for autoinjectors with an optically transparent window.

40

40

Drug Topics

JUNE 1, 2025

Joey Mattingly, PharmD, MBA, PhD, and Marta Wosinska, PhD, discussed what pharmacy businesses can do to prepare for the potential implementation of tariffs on pharmaceutical products.

482

482

PharmTech

JUNE 1, 2025

Download this Case Study to learn how a purging process qualification study was performed using rapid non-destructive headspace oxygen analysis in an at-line set-up with samples being measured immediately from the line.

40

40

STAT

JUNE 1, 2025

CHICAGO — An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new study. The benefit from the study’s exercise program was about as large as what researchers might expect from a new drug, experts said, and came from a randomized controlled trial, the gold standard of medical research.

Chemotherapy 129

Chemotherapy 129

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmTech

JUNE 1, 2025

As described in the chapter subsection USP Package Seal Quality Test Methods, the measurement of residual seal force (RSF) indicates the quality of the vial package seal, giving insight into the quality of the sealing process. Correlating RSF to CCI data enables optimization and validation of the vial sealing process with parameters that give assurance of good CCI.

Packaging 40

Packaging 40

Pharmacy Times

JUNE 1, 2025

Kausik K. Ray, MD, discussed the importance of early, aggressive, and sustained LDL-C lowering for atherosclerotic cardiovascular disease prevention, highlighting that the magnitude of cardiovascular risk reduction is independent of the specific lipid-lowering therapy used.

86

86

PharmTech

JUNE 1, 2025

Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.

40

40

STAT

JUNE 1, 2025

This is the web version of STAT’s  special newslette r from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter  here. We’re going to get to today’s new data in a minute, but first let’s deal with a less serious matter: the marketing of pharmaceutical products via the food attendees need to consume at giant medical meetings.

81

81

Oswald's

JUNE 1, 2025

Last month, I wrote about my third great-grandfather, William Wallace WickelGrandpa Wickelwho ran the pharmacy from 1877 to 1915. In 1915, his son-in-law, Louis Oswald, purchased the pharmacy and would go on to have the longest tenure in our family’s history, running Oswalds until 1955. He then passed it on to his daughter and son-in-law, Harold Kestermy great-grandfather.

52

52

Med Ed 101

JUNE 1, 2025

When patients have anemia, supplements often get prescribed. To many of our polypharmacy patients, excessive prescribing can lead to an increase in pill burden that may not always be necessary. When looking at deprescribing supplements, anemia is an excellent disease state to reassess. Vitamin B12, iron, and folic acid are excellent targets for deprescribing supplements […] The post Deprescribing Supplements in Anemia appeared first on Med Ed 101.

52

52

The FDA Law Blog

JUNE 1, 2025

By Charles D. Snow & Dara Katcher Levy In a recent letter to FDA Commissioner Dr. Martin Makary, U.S. Senator Dick Durbin (D-IL) expressed concerns over the agencys ability to regulate direct-to-consumer (DTC) prescription drug advertisements following recent workforce reductions. In his letter, Senator Durbin highlighted FDAs critical role in ensuring that pharmaceutical advertisements are truthful, not misleading, and provide balanced information and asked a number of questions including

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA Compounding 59

STAT

JUNE 1, 2025

In an interview meant to clarify the federal government’s position on Covid-19 vaccines, Food and Drug Administration Commissioner Marty Makary had few answers. Instead, he urged Americans to consult with their doctors.   In a Sunday appearance on CBS News’ “Face the Nation,” Makary said the data on Covid shots in healthy children and pregnant people are mixed, and said the decision on whether to get vaccinated should be between patients and their doctors.

Vaccines 141

Vaccines FDA 141

STAT

JUNE 1, 2025

CHICAGO — Each year, 40,000 cancer researchers, doctors, and industry executives gather here for the biggest meeting in oncology. And for seven years, it has been almost assumed that the medicines generating the most buzz will come from AstraZeneca. Perhaps that’s why, in a wood-paneled conference room at the St. Regis Hotel far from the hubbub of the American Society of Clinical Oncology’s annual meeting, Pascal Soriot, AstraZeneca’s often pugilistic CEO, was so at e

Vaccines 107

Vaccines 107